IRIS
Paoletti, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.613
NA - Nord America 2.522
EU - Europa 841
SA - Sud America 507
AF - Africa 110
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.618
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.458
SG - Singapore 1.611
BR - Brasile 421
CN - Cina 409
IT - Italia 255
VN - Vietnam 240
FI - Finlandia 96
IE - Irlanda 88
DE - Germania 74
HK - Hong Kong 65
IN - India 60
GB - Regno Unito 58
FR - Francia 56
NG - Nigeria 55
NL - Olanda 40
AR - Argentina 38
BD - Bangladesh 34
RU - Federazione Russa 29
CA - Canada 25
MX - Messico 24
SE - Svezia 22
IQ - Iraq 20
PK - Pakistan 20
ZA - Sudafrica 20
AU - Australia 19
ES - Italia 19
TR - Turchia 19
ID - Indonesia 18
JP - Giappone 17
CZ - Repubblica Ceca 16
AT - Austria 13
EC - Ecuador 13
PL - Polonia 13
UA - Ucraina 13
EG - Egitto 12
CL - Cile 11
SA - Arabia Saudita 11
BE - Belgio 10
CO - Colombia 8
IL - Israele 8
LT - Lituania 7
MY - Malesia 7
NP - Nepal 7
PH - Filippine 7
KE - Kenya 6
TW - Taiwan 6
AL - Albania 5
SN - Senegal 5
UZ - Uzbekistan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
IR - Iran 4
JO - Giordania 4
KG - Kirghizistan 4
KR - Corea 4
KZ - Kazakistan 4
LB - Libano 4
LV - Lettonia 4
MA - Marocco 4
PE - Perù 4
PT - Portogallo 4
PY - Paraguay 4
TH - Thailandia 4
BG - Bulgaria 3
CH - Svizzera 3
TN - Tunisia 3
AZ - Azerbaigian 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
HR - Croazia 2
HU - Ungheria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
FJ - Figi 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IM - Isola di Man 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
NO - Norvegia 1
Totale 6.611
Salva come PNG Salva come JPEG
Città #
Singapore 672
Ashburn 305
San Jose 250
The Dalles 242
Chandler 218
Shanghai 184
Wilmington 139
Dallas 128
Helsinki 95
Boardman 93
New York 93
Dublin 87
Ho Chi Minh City 80
Beijing 75
San Mateo 63
Hong Kong 58
Hanoi 57
Benin City 54
Los Angeles 50
Milan 37
Santa Clara 35
Lawrence 33
Princeton 33
Ann Arbor 29
Paris 29
São Paulo 29
Leawood 24
Naples 22
Amsterdam 20
London 20
Seattle 20
Orem 19
Council Bluffs 18
Phoenix 17
Belo Horizonte 14
Fairfield 14
Curitiba 12
Frankfurt am Main 12
Rome 12
Warsaw 12
Tokyo 11
Assago 10
Boston 10
Brasília 10
Da Nang 10
Pune 10
Brno 9
Cairo 9
Chennai 9
Falkenstein 9
Genoa 9
Haiphong 9
Munich 9
Rio de Janeiro 9
Stockholm 9
Woodbridge 9
Brooklyn 8
Corigliano Calabro 8
Hải Dương 8
Johannesburg 8
Mumbai 8
Porto Alegre 8
San Francisco 8
Atlanta 7
Campinas 7
Guarulhos 7
Hyderabad 7
Montreal 7
Newark 7
Ambivere 6
Buffalo 6
Denver 6
Guayaquil 6
Jumet 6
Mexico City 6
Nuremberg 6
Parma 6
Secaucus 6
Buenos Aires 5
Can Tho 5
Cape Town 5
Dakar 5
Houston 5
Joinville 5
Moscow 5
Olomouc 5
Philadelphia 5
Rochester 5
Sydney 5
Vienna 5
Bishkek 4
Brussels 4
Campo Grande 4
Chicago 4
Florence 4
Harbin 4
Hillsboro 4
Itu 4
Jeddah 4
Lahore 4
Totale 3.807
Salva come PNG Salva come JPEG
Nome #
NAPPREB study protocol: A pivotal clinical trial to investigate clinical efficacy and potential response biomarkers to Benralizumab treatment in chronic rhinosinusitis with nasal polyps 161
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 132
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model 119
An academic allergy unit during COVID-19 pandemic in Italy. 116
Asthma from immune pathogenesis to precision medicine 93
Treatable traits in chronic rhinosinusitis with nasal polyps 93
Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis 93
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 93
Allergen immunotherapy and biologics in respiratory allergy: friends or foes? 91
New therapeutic approaches with biological drugs for eosinophilic granulomatosis with polyangiitis 89
One year of mepolizumab. Efficacy and safety in real-life in Italy 84
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma 84
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence" 84
Alpha1-antitrypsin deficiency and asthma 84
Inappropriate prescription of benzodiazepines in acutely hospitalized older patients 82
Interleukin-5 in the Pathophysiology of Severe Asthma 80
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 79
Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets 78
New drugs in early-stage clinical trials for allergic rhinitis 78
Validation of the Italian version of the Test of Adherence to Inhalers (TAI) 77
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 77
Advancing Precision Medicine in Asthma: Evolution of Treatment Outcomes 73
Do the current guidelines for asthma pharmacotherapy encourage over-treatment? 73
The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life. 72
Validation and Qualification of Biomarkers and Their Translation Into Pathway-Specific Diagnostic Tests 72
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 72
Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease? 71
Community pharmacist's professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists 71
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 70
Immunostimulants in respiratory diseases: Focus on Pidotimod 70
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments 69
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 68
Impact of asthma on bronchiectasis severity and risk of exacerbations 67
Nasal Polyposis Quality of Life (NPQ): Development and Validation of the First Specific Quality of Life Questionnaire for Chronic Rhinosinusitis with Nasal Polyps 66
Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 65
Biologic drugs and allergen immunotherapy: potential allies 62
Small airway dysfunction and obesity in asthmatic patients: a dangerous liaison? 62
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 61
Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital 59
Biologics and airway remodeling in severe asthma 57
SANI Clinical Remission definition: a useful tool in Severe Asthma management 55
Allergen immunotherapy in Italy: How, when, and why—A real-world study conducted through a patient association 54
Antibiotic use and associated factors in a large sample of hospitalised older people 54
Artificial intelligence processing electronic health records to identify commonalities and comorbidities cluster at Immuno Center Humanitas 53
Comorbid allergic rhinitis and asthma: important clinical considerations 52
Gastroesophageal reflux and asthma: when, how, and why 52
COPD and biologic treatment: state of the art 52
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine 51
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? 51
Care for Patients with Type-2 Chronic Rhinosinusitis 50
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 50
Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines 49
Radiological Versus Clinical 1-Year Outcomes of Dupilumab in Refractory CRSwNP: A Real-Life Study 49
Biologics in severe asthma: the role of real-world evidence from registries 49
Oral Immunotherapy with Standardized Peanut Extract: A Game-Changer for Peanut Allergy 49
Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI 49
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 47
Sleep quality burden in chronic rhinosinusitis with nasal polyps and its modulation by Dupilumab 47
A 300 IR 5-grass pollen sublingual immunotherapy tablet-specific systematic review and meta-analysis confirms its clinical benefits for patients with allergic rhinoconjunctivitis with or without asthma 47
Local Allergic Rhinitis: Lights and Shadows of a Mysterious Entity 46
Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patients 46
Asthma severity: the patient’s point of view 45
Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation 45
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 45
Real-world data: A relevant component in the framework of scientific evidence 45
Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: Prevalence, clinical associations, and impact on asthma control 44
The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital 44
Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate 44
Comparability of Asthma Control Test (ACT) scores between self and physician administered test 44
Prevalence of familial link in patients affected by chronic rhinosinusitis with nasal polyposis 43
Vocal biomarkers correlate with FEV1 variations during methacholine challenge 43
Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions 43
Critical evaluation of asthma biomarkers in clinical practice 43
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 42
Real-world effectiveness of mepolizumab in asthma: a systematic review and meta-analysis 41
Exhaled nitric oxide in asthma: from diagnosis to management 41
Use, Abuse, and Misuse of Nasal Medications: Real-Life Survey on Community Pharmacist's Perceptions 41
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy 41
Oral Corticosteroid Abuse and Self-Prescription in Italy: A Perspective from Community Pharmacists and Sales Reports before and during the COVID-19 Era 41
ARIA–Italy managing allergic rhinitis and asthma in a changing world: The role of the Pharmacist 41
Clinical remission in severe asthma: lights and shadows on an ambitious goal 41
Editorial comment on “Environmental influences on childhood asthma: Climate change” 40
Statistical advice provided by ChatGPT regarding an accepted article in Allergy 40
Vaping effects on asthma: results from a web survey and clinical investigation 40
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 39
Personalizing the approach to asthma treatment 39
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 38
Editorial: pharmacotherapy and evidence-based medicine section 37
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis 37
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 37
The Present and Future of Allergen Immunotherapy in Personalized Medicine 37
The Use of Molecular Allergy Diagnosis in Anaphylaxis: a Literature Review 37
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study 37
New evidence in food allergies treatment 37
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders 36
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 35
Outcomes of Non‐Mucosa Sparing Endoscopic Sinus Surgery (Partial Reboot) in Refractory Chronic Rhinosinusitis with Nasal Polyposis: An Academic Hospital Experience 35
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 35
Questionnaire Validation: A User Guide for Allergy Research 35
Editorial: pharmacotherapy and evidence-based medicine 35
Totale 5.862
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.049
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 27 3 32
2021/2022191 4 1 11 41 0 0 4 29 8 22 59 12
2022/2023618 80 48 50 75 65 40 0 41 112 46 43 18
2023/2024868 76 68 164 37 34 85 72 44 21 36 72 159
2024/20251.434 69 25 28 30 38 137 77 108 254 302 161 205
2025/20263.381 484 231 229 398 209 177 1.015 226 220 192 0 0
Totale 6.761